Wall Street brokerages forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report earnings of $0.55 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Acadia Healthcare’s earnings, with the highest EPS estimate coming in at $0.56 and the lowest estimate coming in at $0.54. Acadia Healthcare reported earnings of $0.59 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 6.8%. The firm is scheduled to announce its next quarterly earnings report on Thursday, February 22nd.
According to Zacks, analysts expect that Acadia Healthcare will report full-year earnings of $2.23 per share for the current financial year, with EPS estimates ranging from $2.20 to $2.25. For the next year, analysts anticipate that the company will report earnings of $2.44 per share, with EPS estimates ranging from $2.27 to $2.63. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). The firm had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The firm’s quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.58 earnings per share.
A number of analysts recently commented on ACHC shares. Jefferies Group set a $60.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a research note on Wednesday, October 11th. Citigroup lowered their target price on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Cantor Fitzgerald lowered their target price on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a research note on Tuesday, October 24th. Deutsche Bank cut shares of Acadia Healthcare from a “buy” rating to a “hold” rating and lowered their target price for the stock from $60.00 to $37.00 in a research note on Wednesday, October 25th. Finally, Zacks Investment Research cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, October 12th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $44.17.
Acadia Healthcare (NASDAQ ACHC) traded up $0.03 during mid-day trading on Tuesday, reaching $33.46. 2,943,000 shares of the company were exchanged, compared to its average volume of 1,778,567. The firm has a market cap of $2,936.95, a PE ratio of 16.98, a PEG ratio of 1.14 and a beta of 0.90. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a one year low of $26.92 and a one year high of $54.34.
In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Atlantic Trust Group LLC raised its position in Acadia Healthcare by 22.3% during the 3rd quarter. Atlantic Trust Group LLC now owns 306,554 shares of the company’s stock worth $14,642,000 after buying an additional 55,997 shares during the last quarter. Arthur Zaske & Associates LLC purchased a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $283,000. Neuberger Berman Group LLC increased its holdings in shares of Acadia Healthcare by 5.1% during the 3rd quarter. Neuberger Berman Group LLC now owns 879,951 shares of the company’s stock valued at $42,026,000 after purchasing an additional 42,713 shares in the last quarter. Granahan Investment Management Inc. MA increased its holdings in shares of Acadia Healthcare by 11.6% during the 3rd quarter. Granahan Investment Management Inc. MA now owns 69,011 shares of the company’s stock valued at $3,296,000 after purchasing an additional 7,186 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $316,000.
TRADEMARK VIOLATION WARNING: “Brokerages Expect Acadia Healthcare Company, Inc. (ACHC) Will Post Earnings of $0.55 Per Share” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://ledgergazette.com/2018/01/12/brokerages-expect-acadia-healthcare-company-inc-achc-will-post-earnings-of-0-55-per-share.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.